Literature DB >> 16254565

Current issues in mouse genome engineering.

Stefan Glaser1, Konstantinos Anastassiadis, A Francis Stewart.   

Abstract

The mouse is the foremost vertebrate experimental model because its genome can be precisely and variously engineered. Now that the mouse genome has been sequenced and annotated, the task of mutating each gene is feasible, and an international cooperation is providing mutated embryonic stem cells and mice as readily available resources. Because these resources will change biomedical research, decisions about their nature will have far-reaching effects. It is therefore timely to consider topical issues for mouse genome engineering, such as the background genotype; homologous, site-specific and transpositional recombination; conditional mutagenesis; RNA-mediated interference; and functional genomics with embryonic stem cells.

Entities:  

Mesh:

Year:  2005        PMID: 16254565     DOI: 10.1038/ng1668

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  61 in total

1.  Controlled gene expression in primary Lgr5 organoid cultures.

Authors:  Bon-Kyoung Koo; Daniel E Stange; Toshiro Sato; Wouter Karthaus; Henner F Farin; Meritxell Huch; Johan H van Es; Hans Clevers
Journal:  Nat Methods       Date:  2011-12-04       Impact factor: 28.547

2.  Segment- and cell-specific expression of D-type cyclins in the postnatal mouse epididymis.

Authors:  Huizhen Wang; T Rajendra Kumar
Journal:  Gene Expr Patterns       Date:  2012-01-24       Impact factor: 1.224

Review 3.  Virtues and limitations of the preimplantation mouse embryo as a model system.

Authors:  Robert A Taft
Journal:  Theriogenology       Date:  2007-11-19       Impact factor: 2.740

4.  Skeletal muscle-specific Cre recombinase expression, controlled by the human α-skeletal actin promoter, improves glucose tolerance in mice fed a high-fat diet.

Authors:  Rami Al Batran; Keshav Gopal; Mackenzie D Martin; Kim L Ho; Malak Almutairi; Hanin Aburasayn; Farah Eaton; Jonathan E Campbell; John R Ussher
Journal:  Diabetologia       Date:  2018-06-01       Impact factor: 10.122

Review 5.  Probing human cardiovascular congenital disease using transgenic mouse models.

Authors:  Paige Snider; Simon J Conway
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

6.  Comparison of male chimeric mice generated from microinjection of JM8.N4 embryonic stem cells into C57BL/6J and C57BL/6NTac blastocysts.

Authors:  Thomas J Fielder; Charles S Yi; Juliet Masumi; Katrina G Waymire; Hsiao-Wen Chen; Shuling Wang; Kai-Xuan Shi; Douglas C Wallace; Grant R MacGregor
Journal:  Transgenic Res       Date:  2012-03-16       Impact factor: 2.788

7.  A conditional knockout resource for the genome-wide study of mouse gene function.

Authors:  William C Skarnes; Barry Rosen; Anthony P West; Manousos Koutsourakis; Wendy Bushell; Vivek Iyer; Alejandro O Mujica; Mark Thomas; Jennifer Harrow; Tony Cox; David Jackson; Jessica Severin; Patrick Biggs; Jun Fu; Michael Nefedov; Pieter J de Jong; A Francis Stewart; Allan Bradley
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

8.  Tissue-specific and reversible RNA interference in transgenic mice.

Authors:  Ross A Dickins; Katherine McJunkin; Eva Hernando; Prem K Premsrirut; Valery Krizhanovsky; Darren J Burgess; Sang Yong Kim; Carlos Cordon-Cardo; Lars Zender; Gregory J Hannon; Scott W Lowe
Journal:  Nat Genet       Date:  2007-06-17       Impact factor: 38.330

9.  The effect on intracytoplasmic sperm injection outcome of genotype, male germ cell stage and freeze-thawing in mice.

Authors:  Narumi Ogonuki; Manami Mori; Akie Shinmen; Kimiko Inoue; Keiji Mochida; Akihiko Ohta; Atsuo Ogura
Journal:  PLoS One       Date:  2010-06-11       Impact factor: 3.240

10.  In ovo RNAi opens new possibilities for temporal and spatial control of gene silencing during development of the vertebrate nervous system.

Authors:  Thomas Baeriswyl; Esther T Stoeckli
Journal:  J RNAi Gene Silencing       Date:  2006-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.